首页> 外国专利> DETERMINATION OF SERUM APO B

DETERMINATION OF SERUM APO B

机译:血清APO B的测定

摘要

PURPOSE:To dispense with the dilution of serum and to obtain a measured value within a short time with good accuracy by using two or more kinds of anti-human apo B monoclonal antibodies having different antigenic determinants to be recognized. CONSTITUTION:The antigen-antibody reaction with serum is performed using two or more kinds of anti-human apo B monoclonal antibodies having different antigenic determinants to be recognized and the turbidity due to the generated antigen-antibody composite is measured spectroscopically. By this method, the dilution of serum becomes unnecessary and measurement can be performed within an extremely short time. For example, when four kinds of monoclonal antibodies are used in combination, antigen-antibody reaction reaches a plateau after about 9min. Further, by this method, serum apo B can be accurately measured up to concentration of at least about 230mg/dl.
机译:目的:通过使用两种或两种以上具有不同抗原决定簇的抗人载脂蛋白B单克隆抗体来免除血清稀释液并在短时间内获得准确的测量值。组成:与血清的抗原抗体反应是使用两种或更多种具有不同待识别抗原决定簇的抗人载脂蛋白B单克隆抗体进行的,并通过光谱法测定由于产生的抗原抗体复合物引起的浊度。通过这种方法,不需要稀释血清,并且可以在极短的时间内进行测量。例如,当四种单克隆抗体组合使用时,抗原-抗体反应在约9分钟后达到平稳状态。此外,通过这种方法,可以精确地测量血清载脂蛋白B直至至少约230mg / dl的浓度。

著录项

  • 公开/公告号JPH0264458A

    专利类型

  • 公开/公告日1990-03-05

    原文格式PDF

  • 申请/专利权人 NIPPON SHOJI KK;

    申请/专利号JP19880217094

  • 申请日1988-08-31

  • 分类号G01N33/53;A61K39/395;C12N5/10;C12N5/16;C12N15/02;C12N15/06;C12P21/08;C12R1/91;G01N33/536;G01N33/577;

  • 国家 JP

  • 入库时间 2022-08-22 06:21:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号